Cargando…
P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
Autores principales: | Mizuhara, K., Kobayashi, T., Nakao, M., Takahashi, R., Kaneko, H., Shimura, K., Hirakawa, K., Uoshima, N., Kamitsuji, Y., Wada, K., Kawata, E., Isa, R., Fujino, T., Matsumura-Kimoto, Y., Tsukamoto, T., Mizutani, S., Shimura, Y., Taniwaki, M., Kuroda, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430938/ http://dx.doi.org/10.1097/01.HS9.0000847376.12611.2e |
Ejemplares similares
-
Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study
por: Mizuhara, Kentaro, et al.
Publicado: (2022) -
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma
por: Okamoto, Haruya, et al.
Publicado: (2021) -
P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA
por: Kawaji-Kanayama, Yuka, et al.
Publicado: (2023) -
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms
por: Onishi, Akio, et al.
Publicado: (2023) -
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma
por: Isa, Reiko, et al.
Publicado: (2022)